Evidence map›Paper›PMID 29295515›Full record

ArticleAntibiotics (Basel, Switzerland)2017

Establishing a System for Testing Replication Inhibition of the Vibrio cholerae Secondary Chromosome in Escherichia coli.

Nadine Schallopp, Sarah Milbredt, Theodor Sperlea, Franziska S Kemter, Matthias Bruhn, Daniel Schindler, Torsten Waldminghaus

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Functionality of Two Origins of Replication inFrontiers in microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nadine SchalloppLOEWE Center for Synthetic Microbiology-SYNMIKRO, Philipps-Universität Marburg, Marburg 35032, Germany. nadine@schallopp.de.
Sarah MilbredtLOEWE Center for Synthetic Microbiology-SYNMIKRO, Philipps-Universität Marburg, Marburg 35032, Germany. Sarah.Milbredt@ruhr-uni-bochum.de.
Theodor SperleaLOEWE Center for Synthetic Microbiology-SYNMIKRO, Philipps-Universität Marburg, Marburg 35032, Germany.
Franziska S KemterLOEWE Center for Synthetic Microbiology-SYNMIKRO, Philipps-Universität Marburg, Marburg 35032, Germany. Kemter@students.uni-marburg.de.
Matthias BruhnLOEWE Center for Synthetic Microbiology-SYNMIKRO, Philipps-Universität Marburg, Marburg 35032, Germany. bruhnmatthias@aol.com.
Daniel SchindlerLOEWE Center for Synthetic Microbiology-SYNMIKRO, Philipps-Universität Marburg, Marburg 35032, Germany. daniel.schindler@manchester.ac.uk.
Torsten WaldminghausLOEWE Center for Synthetic Microbiology-SYNMIKRO, Philipps-Universität Marburg, Marburg 35032, Germany. torsten.waldminghaus@synmikro.uni-marburg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulators of DNA replication in bacteria are an attractive target for new antibiotics, as not only is replication essential for cell viability, but its underlying mechanisms also differ from those operating in eukaryotes. The genetic information of most bacteria is encoded on a single chromosome, but about 10% of species carry a split genome spanning multiple chromosomes. The best studied bacterium in this context is the human pathogen

Indexed as

chromosome engineeringdrug developmentreplication initiation

Identifiers

PMID29295515
PMCPMC5872114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.